[CapitalWatch] Chinese Companies Reconsider IPO Plans Amid Coronavirus - capitalwatch.com - via
Author: CapitalWatch Staff
The COVID-19 has affected capital exchanges in more ways than just weighing down on certain stocks. So far, the coronavirus has delayed a number of China deals, initial public offerings included. And while that can partially be attributed to the difficulties of travel and avoidance of face-to-face negotiations on fears of spreading the infection, some companies' operations in the country remain on hold or experience major setbacks, bound to weigh on investor interest and negatively impact valuations.
One such China company was 58 Home. Suffering from weakened customer demand, the company has put its $2 billion U.S. debut on hold, Bloomberg reported on Thursday. The household services platform, operated by 58.com Inc. (NYSE: WUBA), was expected to become publicly traded in the first half-year. Bloomberg also reported the company failed to close its funding round kicked off in late 2019, and is seeing its business turn sour as the Chinese are limiting their interactions with others.
In addition, as the Financial Times reported on Tuesday, buyers have put off acquisitions in hopes of price cuts. The FT said deals under threat included Megvii, a Chinese face-recognition unicorn, which has been cleared for a $500 million Hong Kong IPO in January.
Earlier in February, reports surfaced that InnoCare Pharma, a Chinese developer of treatments for autoimmune diseases and cancer, delayed its IPO because of the coronavirus. The company was targeting to raise $200 million on the Stock Exchange of Hong Kong.
Last week, Huize Holding Ltd. (Nasdaq: HUIZ) chose to proceed with its IPO, though its $55.1 million flotation - a third of what the company targeted earlier - was majority-bought by corporate investors. As the Nasdaq reported, just four outside investors purchased 60% of the shares in the deal, kicked off Wednesday. The three-day run left the online insurance platform in the green on Friday, at $10.60 per American depositary share, 10 cents above its offering price. The company first filed for an IPO in early September.
Separately, three of five SPACs in New York in the past week were Chinese. They were CITIC Capital Acquisition (CCAC), which raised $240 million, Wuhan-based Yunhong International (ZGYHU), with a $60 million offering, and Shanghai-based Newborn Acquisition (NBACU) raised $50 million.
Since Jan. 23, when authorities cut off transportation from Wuhan, the center of the epidemic, no Chinese company publicly filed for a New York offering, while a number of runners are still in the IPO queue.
More News in News
China's worst-hit province Hubei has intensified its lockdown measures by banning vehicle traffic in the latest move to contain the spread of the coronavirus. A provincial government notice yesterday said all cars, except ambulances, police cars
The ban was later lifted, and the animals reappeared. Now another coronavirus is spreading through China, so far killing 1380 people and sickening more than 64,000 - eight times the number sickened by SARS.
OTTAWA - The Canadian Federation of Nurses Unions is warning that the federal public health agency's guidelines to protect front-line health-care workers from outbreaks of diseases like the novel coronavirus don't go far enough, and
LANGLEY (NEWS 1130) - Some long-awaited relief for a father from Fort Langley, after his son was finally evacuated from a quarantined cruise ship near Japan. After weeks of uncertainty, Scott Fehrenbacher says his son Spencer
In a popular Catholic church in the Philippines, nearly half of the pews were empty for Sunday Mass. The few hundred worshippers who showed up were asked to refrain from shaking others' hands or holding